In addition, MAGEA4 overexpression has been implicated in numerous cancers and MAGEA4 has long been identified as a promising target for T-cell-based immunotherapy (Duffour et al, 1999; Shichijo et al, 1995; Davari et al, 2021; Sanderson et al, 2020). This evidence concerns the gene MAGEA4 and cancer.